In documents tabled in the House of Commons on Jan. 30, Health Canada responded to COVID-19 vaccination questions submitted by Conservative MP Collin Carrie on issues such as adverse events, the “gene therapy” nature of the mRNA shots, and lingering spike protein.
Carrie asked a broad range of technical questions, such as whether the Pfizer clinical trials had tested for “biomarkers (e.g. troponin-1 as an indicator for heart damage, C-reactive protein for inflammation) associated with possible vaccine adverse effects related to spike protein in the blood circulation.”
